Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers

Journal of the National Cancer Institute

Volumn 93, Issue 21, 2001, Pages 1633-1637

  Hartmann, Lynn C ^a   Sellers, Thomas A ^a   Schaid, Daniel J ^a   Frank, Thomas S ^b   Soderberg, Cheryl L ^a   Sitta, Diana L ^a   Frost, Marlene H ^a   Grant, Clive S ^a   Donohue, John H ^a   Woods, John E ^a   McDonnell, Shannon K ^a   Vockley, Catherine Walsh ^a   Deffenbaugh, Amie ^b   Couch, Fergus J ^a   Jenkins, Robert B ^a  

^a MAYO CLINIC   (United States)

^b Myriad Genetic Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; FOLLOW UP; GEL ELECTROPHORESIS; GENE MUTATION; GENETIC SCREENING; HETEROZYGOTE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MASTECTOMY; PENETRANCE; PRIORITY JOURNAL; PROTEIN CONFORMATION; RETROSPECTIVE STUDY; RISK MANAGEMENT; SEQUENCE ANALYSIS; TREATMENT OUTCOME;

EID: 0035824069     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/93.21.1633     Document Type: Article

References (19)

1. Breast and ovarian cancer incidence in BRCA1-mutation carriers: Breast Cancer Linkage Consortium
2. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews
3. Cancer risks in BRCA2 mutation carriers
4. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer
5. Sequence analysis of BRCA1 and BRCA2: Correlation of mutations with family history and ovarian cancer risk
6. Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: Evidence for solvent-induced bends in DNA heteroduplexes
7. BRCA2 germline mutations in male breast cancer cases and breast cancer families
8. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer
9. p73 mutations are not detected in sporadic and hereditary breast cancer
10. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
11. Moderate frequency of BRCA1 and BRCA2 germline mutations in Scandinavian familial breast cancer
12. ACMG recommendations for standards for interpretation of sequence variations
13. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation
14. BRCA1 and BRCA2 mutations in breast cancer families with multiple primary cancers
15. BRCA1 testing- advances and retreats
16. Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions
17. Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing